Carnitine plays a central role in lipid metabolism by transporting long-chain fatty acids into the mitochondria for @-oxidation. Reduction of carnitinc concentration docs not automatically imply that functional carnitine deficiency exists with direct consequences on energy metabolism. In our experimental model, we reduced tissue concentrations of carnitine to levels that arc comparable to those in patients with various metabolic disorders with secondary carnitine deficiency and did a study on the in vivo effects of moderate carnitine depletion on palmitate oxidation, excrcise capacity, and nitrogen balance. Thirty rats were divided into a carnitine-depleted group (group I) and pair-fed controls (group 11). Carnitine depletion resulting in a 48% reduction of tissue carnitine concentrations was induced by feeding ad libitum a carnitine-free oral diet consisting of parenteral nutrition solutions. Palmitate oxidation was measurcd by collecting cxpircd "CO, after an intrapcritoncal injection of [l-'JC]palmitatc, and exercise capacity was dctcrmined by having thc rats swim to exhaustion. Despite thc 48% dcplction of carnitinc in serum, muscle, and liver, there wcrc no diffcrcnccs in cumulative palmitate oxidation in 3 h (group I, 40 5 7%; group 11, 37 5 9% of injected activity), swimming time to exhaustion (group I, 8.1 5 2.8 h; group 11, 7.7 + 3.6 h), or nitrogen balance (group I, 1.1 r 0.5 g of nitrogenlkgld; group 11, 1.2 +-0.5 g of nitrogcnkgld). We concludc that carnitinc depiction of 48% has no effect on palmitatc oxidation, exercise capacity, or nitrogen balance in the rats studied. 
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Abbreviations TPN, total parcnteral nutrition Carnitine plays a central role in lipid metabolism. Its main function is to transport long-chain fatty acids from the cytosol into the mitochondrial matrix for p-oxidation (1). Without carnitine, long-chain fatty acids are unable to penetrate the mitochondrial membrane. Carnitine also modulates C o A metabolism and ketogenesis (2, 3). F F A are important source of energy during fasting and also in the resting muscles (4). During low-intensity exercise the utilization of fatty acids b y muscles is increased, and during prolonged exercise fatty acid oxidation eventually becomes the major energy source for muscles (4) . Carnitine also improves nitrogen metabolism by stimulation of the oxidation of branched-chain amino acids in the muscle (5) and improves nitrogen balance during experimental TPN (6, 7).
L-Carnitine has been described in the literature a s a "conditionally essential nutrient." Most often, preterm individuals, term infants, and patients fed entirely parenterally are suggested to require exogenous carnitine (8) .
Primary carnitine deficiency is caused b y a defect of carnitine transport into the cells and inability to establish a concentration gradient over the cell membrane (9-1 1). Carnitine deficiency manifests in childhood a s recurrent attacks of hepatic encephalopathy o r progressive cardiomyopathy, muscle weakness, and lipid storage myopathy (12). Concentration of carnitine in the muscle is extremelv low (9. 12) and the utilization of Although primary carnitine deficiency inevitably impairs fatty acid oxidation, the metabolic and physiologic consequences of moderately reduced tissue concentrations of carnitine in other clinical conditions have not been established. Low tissue carnitine concentration as a secondary phenomenon has been found in many metabolic disorders, e.g. defects in p-oxidation, citric acid cycle, respiratory chain, organic acid metabolism, and amino acid metabolism (9, (15) (16) (17) . Furthermore, drugs like valproate, pivampicillin, and pivmecillinam, which induce excessive urinary loss of carnitine (15, 18) , lead to low tissue concentrations of carnitine. The patients with secondary carnitine deficiency have moderately decreased concentrations of carnitine, but the effect of moderately decreased tissue carnitine on lipid metabolism in vivo is unknown (19) .
We have demonstrated that tissue concentrations of carnitine decrease by 50% after prolonged oral feeding of carnitine-free parenteral nutrition solutions in rats (20) , presumably because the endogenous synthesis of carnitine is insufficient for the maintenance of normal tissue carnitine concentrations. In this depletion model, tissue carnitine concentrations are reduced by approximately SO%, which is comparable to the reductions commonly observed in secondary carnitine deficiency (21) .
The aim of this study was to assess the effects of this 50% reduction of tissue carnitine concentrations on the oxidation of palmitate in vivo, exercise capacity, and nitrogen balance in rats.
METHODS
This study was approved by the Ethics Committee of Turku University.
Animals. Thirty young male Wistar rats (aged 4-5 wk, weight 130-170 g) were randomly assigned to two groups. The rats were housed in individual cages under controlled conditions (lights on from 0700 to 1900 h, temperature 22 * 1°C, and 60% relative humidity) and were weighed weekly after an 8-h fast.
Diet. Carnitine depletion was induced in 15 rats (group I) by feeding ad libitum an oral diet consisting of carnitine-free TPN solutions. Another group of 15 rats (group 11) was pair-fed a standard laboratory pellet diet (Ewos R3, Ewos Company, Sodertalje, Sweden). The measured carnitine content of the normal pellet diet was 60 nmollg. The experimental carnitine-free diet consisted of parenteral nutrition infusates given orally. This diet contained 403 kJ (96.5 kcal) of energy, 0.7 g of nitrogen, and 5.3 g of amino acids per 100 mL and it has been described in detail (20) . The diet was obtained by mixing an 8.6% amino acid solution (Levamin normo, Huhtamaki OY Leiras, Turku, Finland) with 50% glucose solution (Glucos SO%, Huhtamaki OY Leiras) and 20% fat emulsion (Emulsan 20%, Huhtamaki OY Leiras) (Table  1) . Electrolytes, minerals, trace elements, and vitamins were added. The relative contents of protein and energy were equal in the experimental carnitine-free diet and the pellet diet. The pair-feeding procedure excludes any effect of quantitative differences in the intake of energy and protein. The pair-feeding continued for 7 wk. This feeding protocol results in a 50% reduction of tissue carnitine concentrations in experimental animals, whereas pair-fed controls have normal values (20, 22) . Both groups had five controls for the measurement of tissue carnitine concentrations. After 6 wk of dietary manipulation, carnitine in serum, gastrocnemius and soleus muscles, and liver was analyzed in these rats to confirm the carnitine depletion. Carnitine analysis. Serum and urine samples were analyzed as such, whereas tissue carnitine analyses were performed on the neutralized supernatant after perchloric acid precipitation of the tissue homogenate. Free and total acid-soluble carnitine were measured with the radioenzymatic assay (23) with minor modifications. Tris buffer was replaced by 0.1 M KCI, 1 mM EDTA solution (pH 7.0) for free carnitine determination or 0.1 M KOH, 1 mM EDTA solution (pH 12.5) for total acid-soluble carnitine measurement. The hydrolysis, neutralization, and separation of labeled acetylcarnitine from the [I-'4C]acetyl-Co~ by Dowex 2-X8 mesh 100-200 (Clform) anion-exchange resin (Bio-Rad Laboratories, Richmond, CA) were done according the original method of Cederblad and Lindstedt (24). Total acid-soluble carnitine was determined after alkaline hydrolysis and free carnitine was measured directly. Acylcarnitine was calculated by subtracting free carnitine from the total. Normal values of tissue carnitine concentrations from our laboratory have been previously reported (22).
Palmitate oxihtwn in vivo. During the 7th wk of the experiment, palmitate oxidation was measured after an 8-h fast by placing each rat into an individual Plexiglas metabolic cage for a period of 3 h. A constant flow of 1000 mL 290 HEINONEN AND TAKALA of room air per min was vacuumed through the cage. After 30 min of adaptation, a single dose of 2.0 pCi of [l-'4~]palmitate per 100 g of body weight was given by intraperitoneal injection. Radioactive palmitate (0.1 mCi/mL with a sp act of 58.0 mCilmmol; New England Nuclear, Boston, MA) was complexed to 0.2 mM defatted BSA in 154 mM NaCI. The exact dose injected was determined by weighing the syringe before and after the injection. The air flow from the cage was led through three vials containing 5.0 mL of hyamine hydroxide. The hyamine vials were replaced at 15-min intervals. The "CO, activity was measured after mixing a 1-mL aliquot of the hyamine hydroxide with 10 mL of scintillation counting solution (Carboluma, Lumac, Schaesberg, The Netherlands), and counted with an LKB 1219 Rackbeta scintillation counter (Wallac, Turku, Finland). The total activity consisted of the sum of the activities in the three vials.
Exercise capacity. Exercise capacity was measured later in the 7th week by letting the rats swim to exhaustion (25). Each rat was allowed to swim separately in a Plexiglas tank where the water temperature was adjusted to 35-36°C. Small weights that were 2.0% of the rat's body weight were tied to the tail of the animal to reduce the swimming time and variability between animals.
Nitrogen balance. The total nitrogen was measured in 24-h urine collections by chemiluminescence (26) by an Antek Auto-Analyzer 703C (Antek Instruments Inc., Houston, TX). Nitrogen balance was calculated as the difference between dietary nitrogen according manufacturer's specification and measured urinary nitrogen.
Study design. When studying palmitate oxidation in vivo, exercise capacity, and nitrogen balance, each carnitine-depleted animal was always simultaneously tested with its pair-fed control (Table 2 ).
S t d d c d anufysk.
The results are expressed as mean + SD. Comparison of tissue concentrations of carnitine were made by the t test for matched pairs. Differences in palmitate oxidation in vivo were analyzed by analysis of variance with repeated measures designed for matched pairs with one grouping factor (carnitine treatment) and one within factor (time). Otherwise, analysis of variance for matched pairs with one grouping factor (carnitine treatment) and covariate (weight) was used. The normality of the distributions and equality of group variances were tested. A p value of less than 0.05 was considered significant.
RESULTS

Carnitine depletion model. The feeding protocol resulted
in normal carnitine concentration in serum, muscle, and Table 2 . Stu liver in the pair-fed controls, whereas a decrease of tissue carnitine to 50-52% of normal was observed in the depleted group (Table 3) , reproducing our previous results with the same model (20) . The mean daily consumption of the experimental carnitine-free liquid diet was 75 2 5, 101 + 6,84 + 14,78 + 15,Xl -+ 12, and 91 + 9 mL during wk 1, 2, 3,4,5, and 6, respectively. The corresponding mean daily intake of energy was 302 5 20,409 + 23,337 + 58, 314 + 62, 325 + 47, and 367 5 35 kJ and that of nitrogen was 0.5 + 0.03, 0.7 + 0.004, 0.6 5 0.1, 0.5 5 0.1, 0.6 + 0.08 and 0.6 + 0.06 g during wk 1-6. Because of the pair-feeding, the intakes of protein and energy were identical in the normal controls, and fulfilled the requirements for protein and energy of the laboratory rat in both groups studied. The initial mean weights of the rats were similar (158 + 16 and 159 + 16 g), but after 6 wk the mean weight in the carnitine-depleted group was 301 + 24 g and that in the control group was 351 5 27 g (p < 0.01).
Palmitate oxidation. The cumulative oxidation of palmitate in 3 h was similar in the carnitine-depleted rats (40.4 ? 7.3%) and the pair-fed controls (37.1 + 9.3%) (Fig. 1) .
The "CO, activity in the third hyamine vial was less than 3% of the sum of the three-vial collecting system, confirming good trapping efficiency.
Exercise capacity. Exercise capacity, measured as swimming time to exhaustion, was similar in the carnitine-depleted (8.1 + 2.8 h) and the pair-fed rats (7.7 + 3.6 h). No relation was found between body weight and swimming time.
Nitrogen balance. All the animals were in positive nitrogen balance. Carnitine depletion had no effect on nitrogen balance. Nitrogen balance in the depleted rats was 
DISCUSSION
This is the first study on the effects of diet-induced carnitine depletion on palmitate oxidation and exercise capacity in tivo. Previous experimental models of carnitine depletion interfere not only with carnitine but also with other metabolic functions, because they have been induced by deficiency of one of the essential components of carnitine biosynthesis-methionine, lysine, ascorbic acid, iron, or pyridoxal phosphate (20)--or by repeated intraperitoneal injections of the unphysiologic D-form of carnitine (27). The advantage of our approach is the exclusion of carnitine without affecting the intakes of the essential components of endogenous carnitine synthesis (20) . The carnitine depletion model induces carnitine depletion of 50% or more of normal values in serum, muscle, and liver (20) , and the reproducibility of the model was confirmed in this study. It is important that the effects of lack of carnitine are accentuated in young, rapidly growing rats. In the present study, the experimental animals doubled their body weight; just as for young children, carnitine may be regarded as semiessential for growing animals (8) .
Normal carnitine concentrations can be regarded as the tissue carnitine under normal diet. If one defines normal carnitine concentrations as the tissue carnitine occurring with the normal diet, exogenous carnitine is necessary to maintain these levels. However, a precise requirement for any age group cannot be stated, because dose-response studies have not been done (8) . We have previously studied tissue carnitine concentrations in rats in response to various levels of standard laboratory diet and thereby established the normal carnitine concentrations corresponding to a given amount of food intake (20, 22) . In the present study, tissue carnitine concentrations were depleted by 48% to these normal values.
Despite similar protein contents of the two diets, differences in the amino acid composition might have contributed to the carnitine concentrations. Reduced carnitine concentrations due to insufficient amino acid intake in the carnitine-free diet group are unlikely, because the amounts of the carnitine precursor amino acids lysine and methionine were 1.7 and 3.8 times higher in the experimental carnitine-free diet. It is therefore reasonable to assume that the decreased carnitine concentration in group I reflects insufficient capacity of endogenous carnitine synthesis to compensate for the lack of dietary carnitine.
Theoretically, oxidation of [1-l'~]~almitate offers a good estimate of whole-body fat oxidation. We found unsatisfactory reproducibility of "c-palmitate oxidation due to insufficient trapping of '"0,-palmitate when previously published methods were applied in pilot studies. Improved trapping efficiency and the use of a scintillation counting solution with specific affinity for CO, resulted in higher rates of "c-palmitate oxidation than previously reported; nearly 40% of the total injected activity was trapped versus 2 5 1 5 % as reported earlier (28, 29) . Despite these improvements in methodology, there was no difference in the cumulative oxidation of palmitate in 3 h between the carnitine-depleted rats and their pair-fed controls. Some active palmitate may be lost if it is used, e.g. for lipid synthesis, and therefore not creating active CO,. However, we used the conditions favoring fat oxidation (8-h fast) and a collecting system that was optimized for trapping CO,. We believe the high trapping values of "CO, reflect the fact that most of the injected palmitate was directed to fat oxidation and also reflect the high metabolic rate in the small animals.
Our carnitine depletion model induced the major reduction of carnitine in skeletal muscle, where most fatty acid oxidation, the main function of carnitine, takes place under the conditions studied. However, our model provides only limited information on the consequences of carnitine depletion in the liver, where a fasting test and the determination of ketone bodies, glucose, and FFA in blood had been more informative. All established experimental methods for the measurement of exercise capacity are hampered by wide individual variations. Exercise capacity could alternatively have been measured by treadmill; we chose swimming as the exercise, because our pilot study and recent work by Musch et al. (30) suggest that exercise capacity in rats measured by running on treadmill is variable and not reproducible enough. On a treadmill, it is also difficult to achieve running to exhaustion by moderate oxygen uptake. Despite strict control of the exercise conditions, considerable variation was still present. Lipids are the most important substrate source after 1-2 h of exercise at 5040% of maximal oxygen uptake (31). Accordingly, our model represents moderate metabolic stress (32), where lipid oxidation is the predominant energy source. Any major interference of carnitine depletion with lipid oxidation is likely to reduce the exercise capacity. Because substrate oxidation was not measured during the exercise, the normal exercise capacity is an indirect argument for intact lipid oxidation. An alternative explanation is that if any reduction in lipid oxidation did occur this was compensated by other substrates.
The time to fatigue for a given submaximal work load is also dependent on the initial tissue glycogen concentration at the onset of exercise (33), the mode, intensity, and duration of work, the involvement of different muscle groups, the recruitment pattern of fiber types, and physical fitness (31). We assume that the glycogen stores were similar because pair-feeding was performed. The swimming time to exhaustion was clearly more than 2 h in each case, and hence fatty acid oxidation was obviously the main energy source during the exercise. Because differences in substrate oxidation during exercise were not studied, it is possible that the relative contribution of carbohydrates and fat to the energy expenditure was different. Even if that is the case, the possible change in substrate utilization during exercise did not limit the exercise capacity. The similar mean swimming times in both groups support the view that carnitine depletion had no major effect on exercise capacity.
Carnitine supplementation improves nitrogen balance during experimental TPN (6, 7). We speculated that if carnitine depletion causes reduction of nitrogen retention this might also interfere with exercise capacity, but no effect of carnitine depletion on nitrogen balance was
